Al-Omran M - Search Results

1

Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease.

Primary Panel:; Abramson BL, Al-Omran M, Anand SS, Albalawi Z, Coutinho T, de Mestral C, Dubois L, Gill HL, Greco E, Guzman R, Herman C, Hussain MA, Huckell VF, Jetty P, Kaplovitch E, Karlstedt E, Kayssi A, Lindsay T, Mancini GBJ, McClure G, McMurtry MS, Mir H, Nagpal S, Nault P, Nguyen T, Petrasek P, Rannelli L, Roberts DJ, Roussin A, Saw J, Srivaratharajah K, Stone J, Szalay D, Wan D; Secondary Panel:; Cox H, Verma S, Virani S. Primary Panel:, et al. Can J Cardiol. 2022 May;38(5):560-587. doi: 10.1016/j.cjca.2022.02.029. Can J Cardiol. 2022. PMID: 35537813

2

Clinical decision making for endovascular repair of abdominal aortic aneurysm.

Al-Omran M, Verma S, Lindsay TF, Weisel RD, Sternbach Y. Al-Omran M, et al. Circulation. 2004 Dec 7;110(23):e517-23. doi: 10.1161/01.CIR.0000148961.44397.C7. Circulation. 2004. PMID: 15583084 No abstract available.

3

Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor?

Al-Omran M, Lindsay TF. Al-Omran M, et al. Can J Cardiol. 2005 Feb;21(2):189-93. Can J Cardiol. 2005. PMID: 15729421 Review.

4

Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.

Al-Omran M, Lindsay TF, Major J, Jawas A, Leiter LA, Verma S; Systematic Assessment of Vascular Risk Investigators. Al-Omran M, et al. Ann Vasc Surg. 2006 Sep;20(5):555-63. doi: 10.1007/s10016-006-9110-3. Ann Vasc Surg. 2006. PMID: 16871436

5

Commentary: one-year cardiovascular event rates in outpatients with atherothrombosis. Steg PG, Bhatt DL, Wilson PW, et al; REACH Registry Investigators. JAMA. 2007;297: 1197-1206.

Al-Omran M, Lindsay TF. Al-Omran M, et al. Perspect Vasc Surg Endovasc Ther. 2007 Dec;19(4):416-7. doi: 10.1177/1531003507308795. Perspect Vasc Surg Endovasc Ther. 2007. PMID: 18287158

6

Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.

Al-Omran M, Mamdani MM, Lindsay TF, Melo M, Juurlink DN, Verma S; Systematic Assessment of Vascular Risk Investigators. Al-Omran M, et al. J Vasc Surg. 2008 Sep;48(3):607-12. doi: 10.1016/j.jvs.2008.04.057. Epub 2008 Jun 30. J Vasc Surg. 2008. PMID: 18585886 Free article.

7

Angiotensin receptor blockers vs. angiotensin converting enzyme inhibitors and acute coronary syndrome outcomes in elderly patients: a population-based cohort study (UMPIRE study results).

Verma S, Mamdani MM, Al-Omran M, Melo M, Rouleau JL. Verma S, et al. J Am Soc Hypertens. 2007 Jul-Aug;1(4):286-94. doi: 10.1016/j.jash.2007.05.003. J Am Soc Hypertens. 2007. PMID: 20409860

8

Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital.

Al-Omran M, Verma S, Lindsay TF. Al-Omran M, et al. Ann Saudi Med. 2011 Jul-Aug;31(4):371-5. doi: 10.4103/0256-4947.83219. Ann Saudi Med. 2011. PMID: 21808113 Free PMC article.

9

Validity of vascular trauma codes at major trauma centres.

Altoijry A, Al-Omran M, Lindsay TF, Johnston KW, Melo M, Mamdani M. Altoijry A, et al. Can J Surg. 2013 Dec;56(6):405-8. doi: 10.1503/cjs.013412. Can J Surg. 2013. PMID: 24284148 Free PMC article.

10

Carotid Artery Revascularization: What's the Best Strategy?

Hussain MA, Verma S, Gupta N, Al-Omran M. Hussain MA, et al. Circulation. 2015 Jun 23;131(25):2226-31. doi: 10.1161/CIRCULATIONAHA.114.013017. Circulation. 2015. PMID: 26099955 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

221 results

Search Page